Drug Shortage Report for APO-AMOXI CLAV 125MG/31.25MG PER 5ML
Report ID | 44 |
Drug Identification Number | 02243986 |
Brand name | APO-AMOXI CLAV 125MG/31.25MG PER 5ML |
Common or Proper name | AMOXI CLAV |
Company Name | APOTEX INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | AMOXICILLIN CLAVULANIC ACID |
Strength(s) | 125MG 31.25MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL |
Packaging size | 100 ml |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2014-10-09 |
Estimated end date | Unknown |
Actual end date | 2018-09-08 |
Shortage status | Resolved |
Updated date | 2018-09-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-09-09 | English | Compare |
v4 | 2018-09-08 | French | Compare |
v3 | 2018-09-08 | English | Compare |
v2 | 2017-03-10 | French | Compare |
v1 | 2017-03-10 | English | Compare |
Showing 1 to 5 of 5